Abstract
Context and objectives: The European Association of Urology Guideline Group for renal cell carcinoma (RCC) has prepared these guidelines to help clinicians assess the current evidence-based management of RCC and to incorporate the present recommendations into daily clinical practice. Evidence acquisition: The recommendations provided in the current updated guidelines are based on a thorough review of available RCC guidelines and review articles combined with a systematic literature search using Medline and the Cochrane Central Register of Controlled Trials. Evidence synthesis: A number of recent prospective randomised studies concerning RCC are now available with a high level of evidence, whereas earlier publications were based on retrospective analyses, including some larger multicentre validation studies, meta-analyses, and well-designed controlled studies. Conclusions: These guidelines contain information for the treatment of an individual patient according to a current standardised general approach. Updated recommendations concerning diagnosis, treatment, and follow-up can improve the clinical handling of patients with RCC.
Original language | English |
---|---|
Journal | European Urology |
Volume | 58 |
Issue number | 3 |
Pages (from-to) | 398-406 |
Number of pages | 9 |
ISSN | 0302-2838 |
DOIs | |
Publication status | Published - 09.2010 |
Research Areas and Centers
- Research Area: Luebeck Integrated Oncology Network (LION)